ArticleBMJ open2022

Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.

Fei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.